Advertisement

  • BRCA: Who Should Be Tested?

    Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.

    by Sue Rochman

  • Our Own Words

    People with cancer and their loved ones find ways for their voices to be heard without filters.

    by Bradley Jones

  • Finding Support in Unlikely Places

    After her diagnosis with ovarian cancer, Patricia Anne Ward noticed that some friends and family pulled away. She found connection outside her usual circles.

    by Patricia Anne Ward

  • Advocacy Spotlight: Sorting Out Priorities

    Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions.

    by Cici Zhang

  • Forward Look

    Little Consensus on Ovarian Cancer Monitoring

    Tests and scans may be overused.

    by Kate Yandell

  • Survivor Profile

    Going Full Bore

    Susan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense.

    by Sue Rochman

  • Forward Look

    Identifying Ovarian Cancer Risk

    Study may help spotlight women who would benefit from risk reduction strategies.

    by Carrie Printz

  • Healthy Habits

    A Cup of Tea?

    Black tea consumption may be associated with a reduced risk of ovarian cancer.

    by Kurt Ullman

  • First Person

    Never Alone: A Family Journey

    A mother and daughter exchange thoughts about their “full-family experience” facing an ovarian cancer diagnosis and treatment.

    by Mary (Dicey) Jackson Scroggins and Nneka Scroggins

  • Survivor Profile

    Regaining Her Balance

    Gymnast Shannon Miller's focus and agility helped her capture seven Olympic medals before she was 20. But the most decorated U.S. gymnast in history struggled to overcome the shock of her ovarian cancer diagnosis and treatment.

    by Kevin Begos

Advertisement
Advertisement

From the AACR

  • Preventing Cervical Cancer

    Cervical cancer now accounts for less than 1% of cancer-related deaths among women in the United States.

  • New FDA Approvals

    The first new anti-cancer therapeutics approved in 2020 are for the treatment of two different types of soft tissue sarcoma.

  • Imaging and Immunotherapy

    Imaging a patient’s cancer—and the responses generated by the immune system—can provide information that may guide treatment decisions.

Advertisement

Video

Handle With Care

Advertisement

social media

donate to the AACR